Pfizer PFE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.7B— | —— | $3.55B+21.2% | $2.93B-1.5% | $2.97B+611% | ||
| $1.61B-4.4% | $1.69B+1.5% | $1.66B+2.3% | $1.63B+0.4% | $1.62B-9.7% | ||
| $272M+20.9% | $225M+11.9% | $201M-1.0% | $203M+19.4% | $170M-4.0% | ||
| $2.62B-51.1% | $5.35B+16.2% | $4.6B— | $0-100% | $2.34B-65.3% | ||
| $436M-48.4% | $845M+40.4% | $602M-2.6% | $618M+9.6% | $564M-38.5% | ||
| $785M+113% | -$6.15B-153% | -$2.43B-162% | $3.95B+20.7% | $3.27B— | ||
| -$2.86B— | $0+100% | -$2.48B+22.5% | -$3.2B+38.9% | -$5.23B-2.2% | ||
| $563M— | —— | —— | $213M-43.2% | $375M+933% | ||
| $2.18B-51.6% | $4.5B+12.5% | $4B— | —— | $1.77B-69.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pfizer generate?
- Pfizer (PFE) generated $12.6B in operating cash flow over the trailing twelve months.
- What is Pfizer's free cash flow?
- After $2.5B of capital expenditures, Pfizer's free cash flow was $12.5B over the trailing twelve months, up 26.6% year over year.
- Where does Pfizer's cash flow data come from?
- Every line is extracted from Pfizer's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
